Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegaserod in Diabetic Gastroparesis
NCT00390975Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jan 2007
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegaserod in diabetic gastroparesis, sponsored by Novartis. Started Jan 2007; status: terminated.
02
Drugs
tegaserod
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT00390975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390975.